Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that do not involve biopsies, a team of clinical research scientists at the Icahn School of Medicine at Mount Sinai has demonstrated.